Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2010
10/14/2010WO2010117014A1 Triazine derivative
10/14/2010WO2010116282A1 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses
10/14/2010WO2010115981A1 7-azadispiro [3.0.4.1] decane-8-carboxamides as hepatitis c virus inhibitors
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
10/14/2010WO2010078369A3 Pyrimidinediamine kinase inhibitors
10/14/2010WO2010068775A3 Alkyne antagonists of lysophosphatidic acid receptors
10/14/2010WO2010068760A3 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/14/2010WO2010041218A3 Oxazolidinyl antibiotics
10/14/2010WO2009044019A9 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
10/14/2010US20100261771 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
10/14/2010US20100261766 Phenyl-Oxetanyl-Derivatives
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261759 Substituted oxazolidinones and their use
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261723 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
10/14/2010US20100261722 Hiv inhibiting 5, 6-substituted pyrimidines
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261720 Heterocyclic compound and pharmaceutical composition thereof
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261714 Inhibitors of hiv replication
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261698 Organic compounds
10/14/2010US20100261697 2-(heterocyclylbenzyl)pyridazinone derivatives
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261679 CSF-1R, Inhibitors, Compositions, and Methods of Use
10/14/2010US20100261665 Kinase inhibitor compounds
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260685 Contrast agents
10/14/2010DE102009015070A1 New phenyl-pyrimidin-2-yl-amine compounds are tyrosine kinase 2 inhibitors useful for treating e.g. rheumatoid arthritis, Crohn's disease, asthma, multiple sclerosis, adult respiratory distress syndrome, allergic alveolitis and uveitis
10/14/2010CA2758047A1 Hepatitis c virus inhibitors
10/14/2010CA2757879A1 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/14/2010CA2756250A1 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2238132A2 Insecticidal compounds
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/13/2010EP2237779A1 Benzothiazole and benzoxazole derivatives and methods of use
10/13/2010EP1994011B1 Sulfonyl benzimidazole derivatives
10/13/2010EP1532141B1 2-pyrrolidin-2-yl- [1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
10/13/2010EP1204642B1 Fungicides
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN101861314A Xinafoate salt of N4-[(2, 2-difluoro-4N-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
10/13/2010CN101861313A Phenyl amino pyrimidine compounds and uses thereof
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101857592A Bibenzoxazine containing imide structure and preparation method thereof
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/12/2010US7812341 Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device
10/12/2010US7812170 Insecticides
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812036 Androgens
10/12/2010US7812031 Pyrimidine derivatives as orexin receptor antagonists
10/12/2010US7812026 Imidazole derivatives having a positive allosteric GABAB receptor modulator effect and methods of use
10/12/2010US7812025 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents
10/12/2010US7812023 Methods of using substituted morpholine derivatives
10/12/2010US7812020 Substituted pyridine derivatives
10/12/2010US7812019 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
10/12/2010US7812018 inhibitors of I kappa B kinase ( IKK-2) 2-amino-9-methyl-9H-pyrido[2,3-b]indole-3-carboxamide, useful for treating inflammatory diseases and cancer
10/12/2010US7812016 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2419552C Substituted pyrazoles
10/07/2010WO2010114179A1 3-[1,4]oxazepane-4-pyrimidone derivatives
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010112545A1 Isoxazoline compounds for combating invertebrate pests
10/07/2010WO2010112475A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
10/07/2010WO2010112124A1 Autotaxin inhibitors
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010111948A1 Arylmethylamine compounds, preparation methods and pharmaceutical uses thereof
10/07/2010WO2010084067A3 Insecticidal compounds
10/07/2010WO2009105969A8 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
10/07/2010US20100256366 Methods and intermediates for preparing pharmaceutical agents
10/07/2010US20100256365 Compounds and methods for kinase modulation, and indications therefor
10/07/2010US20100256364 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
10/07/2010US20100256363 SYNTHESIS OF INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1
10/07/2010US20100256362 Method of producing benzoxazinone-based compound
10/07/2010US20100256361 Thiazole derivatives
10/07/2010US20100256359 Hetero isonipecotic modulators of vanilloid vr1 receptor
10/07/2010US20100256357 Heterocycles useful as inhibitors of carbonic anhydrase
10/07/2010US20100256256 Environment-friendly antifoulants for the prevention of biofouling
10/07/2010US20100256201 Cell differentiation inducer
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 647